SHSAX Mutual Fund

NAV$61.55

Fund Essentials - as of Aug 29, 2025

Net Assets
$2.3B
Expense Ratio
1.09%
Dividend Yield (Current)
10.39%
Holdings
139
Inception Date
Dec 21, 1999
Fund Family
BlackRock, Inc. (US)
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+2.27%
1 Year+10.58%
3 Year+10.49%
5 Year+6.48%
10 Year+11.25%

Asset Allocation

Stocks: 98.80%
Cash: 1.10%
Other: 0.10%

Top Holdings

View All →
TickerNameWeight
JNJJohnson & Johnson7.82%
LLYEli Lilly & Co7.46%
ABTAbbott Laboratories5.90%
BSXBoston Scientific Corp4.66%
ABBVAbbvie Inc4.29%
Top 10 Concentration: 47.54%Report Date: Aug 29, 2025
Download all 139 holdings for SHSAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
10.39%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

SHSAX Mutual Fund Overview

SHSAX Mutual Fund (BlackRock Health Sciences Opportunity Investor A Class) is managed by BlackRock, Inc. (US) with $2.27B in net assets. SHSAX expense ratio is 1.09%, holding 139 positions across sectors including Health Care, Unknown, Financials. Inception date: 1999-12-21.

SHSAX performance shows a YTD return of 2.27%. The 1-year return is 10.58% and the 5-year return is 6.48%. SHSAX dividend yield stands at 10.39%, paid annually.

SHSAX top holdings include Johnson & Johnson (7.8%), Eli Lilly & Co (7.5%), Abbott Laboratories (5.9%), Boston Scientific Corp (4.7%), Abbvie Inc (4.3%). View all SHSAX holdings, sector breakdown, or dividend history.

SHSAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. SHSAX alternatives are available via the screener, along with tax-loss harvesting opportunities.